Ipamorelin & CJC-1295 No-Dac Blend 2.5mg Pre Mixed

Description

Buy Ipamorelin CJC No DAC Pre Mixed Blend 2.5mg

This product is intended for research purposes only. To be used by trained professionals only.

Ipamorelin is a selective growth hormone and has been the subject of significant New Zealand clinical research. One of the most well known properties of Ipamorelin is the ability to act as a muscle restorer and developer, and improving the health of bones. Studies have shown Ipamorelin demonstrates the ability to stimulate insulin release from the pancreas, improve bowel mobility and the functioning of the gastric system [1].

For further information about the research, benefits and side effects of Ipamorelin, including the various products available from Direct Peptides New Zealand, refer to the Ipamorelin category page here.

Research has shown that CJC-1295 no DAC stimulates the growth hormone releasing receptor, resulting in the overall effectiveness of growth hormones. It is similarly highly selective and is known to positively influence bone health, lean body mass, insulin resistance, and the development of muscles [2].

For more detailed information on the research, advantages, and potential side effects of CJC-1295 no DAC, as well as an overview of the range of products offered by Direct Peptides New Zealand, visit the CJC-1295 No Dac category page.

This formula combining the two Ipamorelin CJC No DAC peptides ultimately enhances the overall effects of growth hormones, through stimulating their axis via two different mechanisms. New Zealand Research using Ipamorelin CJC No DAC pre mixed blend in animal subjects has demonstrated that utilising both peptides in one solution increases benefits without producing substantially increased side effects.

The noticeable effect of the Ipamorelin CJC no DAC pre mixed formula is a higher production of growth hormones. This, in turn, most likely leads to improved lean body mass and the more effective and rapid development of muscles. Combining every different factor that this double peptide formula is likely to influence, the overall result would be a significant improvement to metabolic functioning.  

Shop ALL Peptide Blends available from Direct Peptides New Zealand.

Key Features of Ipamorelin and CJC-1295 No DAC Pre Mixed Blend 2.5mg

• Specialised Formulation: Combines the benefits of Ipamorelin and CJC-1295 No DAC for enhanced growth hormone secretion.
• Selective GH Secretagogue: Ipamorelin stimulates specific release of growth hormone, minimising incidental effects on other hormones.
• Sustained Physiological Response: CJC-1295 No DAC extends the duration of GH in the bloodstream, promoting prolonged metabolic effects.
• Convenient Administration: The pre mixed blend ensures ease of use, minimising preparation time and enhancing compliance in research protocols.
• Consistent Dosing: Standardised formulation aids in accurate dosing, allowing for reliable assessment across various experimental settings.
• Applications in Metabolic Health: Targeted for studies on muscle growth, wound healing, fat loss, insulin resistance and overall metabolic performance.
• Pharmacodynamics and Pharmacokinetics Research: Facilitates investigations into the optimal dosing regimens and their physiological effects.
• Advancing GH Research: Contributes to a deeper understanding of therapeutic interventions leveraging GH for health improvements.

Buy Ipamorelin CJC No DAC Pre Mixed 2.5mg Blend from Direct Peptides New Zealand. Our high quality tools are designed to exceed the highest standards in scientific research.

Discover our extensive selection of pre-mixed peptide pens and cutting-edge peptide research supplies at Direct Peptides New Zealand. Uncover the capabilities of Ipamorelin CJC No DAC and its significant implications in growth hormone studies today.

 References:

[1] P B Johansen, J Nowak, C Skjaerbaek, A Flyvbjerg, T T Andreassen, M Wilken, and H Orskov (1999) Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats – Growth Hormone and IGF Research Journal, 1999 Apr, Volume 9 (Issue 2), Pages 106-13.

[2] S L Teichman, A Neale, B Lawrence, C Gagnon, JP Castaigne, and L A Frohman (2005) Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults – The Journal of Clinical Endocrinology and Metabolism, 2006 Mar, Volume 91 (Issue 3), Pages 799-805.

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

BUY Ipamorelin CJC NO DAC Pre Mixed Peptide Blend ONLINE today From New Zealand Direct Peptides